These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 81086)
21. Extreme elevation of serum alpha fetoprotein in decompensated cirrhosis without HCC: an ominous sign. Senturk H; Cumali R Int J Biol Markers; 2007; 22(1):19-23. PubMed ID: 17393357 [TBL] [Abstract][Full Text] [Related]
22. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma. Cui R; Wang B; Ding H; Shen H; Li Y; Chen X Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656 [TBL] [Abstract][Full Text] [Related]
23. Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology - a prospective study. Chaminda SR; Suchintha T; Anuk NM; Supun DA; Bhagya GM; Habarakada LCA; Janaka SH BMC Gastroenterol; 2017 Dec; 17(1):142. PubMed ID: 29207969 [TBL] [Abstract][Full Text] [Related]
24. Screening for hepatocellular carcinoma in patients with advanced cirrhosis. Chalasani N; Horlander JC; Said A; Hoen H; Kopecky KK; Stockberger SM; Manam R; Kwo PY; Lumeng L Am J Gastroenterol; 1999 Oct; 94(10):2988-93. PubMed ID: 10520857 [TBL] [Abstract][Full Text] [Related]
25. [Variable clinical symptoms of hepatocellular carcinoma]. Struve C; Heusermann U Dtsch Med Wochenschr; 1988 Feb; 113(8):294-6. PubMed ID: 2449323 [TBL] [Abstract][Full Text] [Related]
26. Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimation. Melia WM; Johnson PJ; Neuberger J; Zaman S; Portmann BC; Williams R Gastroenterology; 1984 Sep; 87(3):660-3. PubMed ID: 6204905 [TBL] [Abstract][Full Text] [Related]
27. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis. Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630 [TBL] [Abstract][Full Text] [Related]
28. Pattern analysis of serum alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma in liver cirrhosis. Arrigoni A; Andriulli A; Gindro T; Piantino P; Capussotti L; Rizzetto M Int J Biol Markers; 1988; 3(3):172-6. PubMed ID: 2466093 [TBL] [Abstract][Full Text] [Related]
29. Feasibility of α-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea. Ahn DG; Kim HJ; Kang H; Lee HW; Bae SH; Lee JH; Paik YH; Lee JS Korean J Intern Med; 2016 Jan; 31(1):46-53. PubMed ID: 26767857 [TBL] [Abstract][Full Text] [Related]
30. Value of serum alpha-fetoprotein and ferritin in the diagnosis of hepatocellular carcinoma. Tatsuta M; Yamamura H; Iishi H; Kasugai H; Okuda S Oncology; 1986; 43(5):306-10. PubMed ID: 2429242 [TBL] [Abstract][Full Text] [Related]
31. Reference change value for alpha-fetoprotein and its application in early detection of hepatocellular carcinoma in patients with hepatic disease. Trapé J; Botargues JM; Porta F; Ricós C; Badal JM; Salinas R; Sala M; Roca A Clin Chem; 2003 Jul; 49(7):1209-11. PubMed ID: 12816928 [No Abstract] [Full Text] [Related]
32. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma. Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339 [TBL] [Abstract][Full Text] [Related]
33. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study. Ji J; Wang H; Li Y; Zheng L; Yin Y; Zou Z; Zhou F; Zhou W; Shen F; Gao C PLoS One; 2016; 11(4):e0153227. PubMed ID: 27070780 [TBL] [Abstract][Full Text] [Related]
34. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development]. Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920 [TBL] [Abstract][Full Text] [Related]
35. [Radioimmunologic determination of alpha fetoprotein in diagnosis of primary tumors of the liver]. Banfi F Quad Sclavo Diagn; 1975 Jun; 11(2):415-8. PubMed ID: 57625 [TBL] [Abstract][Full Text] [Related]
37. Comparison of alpha1 fetoprotein radioimmunoassay method and liver scanning for detecting primary hepatic cell carcinoma. Tonami N; Aburano T; Hisada K Cancer; 1975 Aug; 36(2):466-70. PubMed ID: 50872 [TBL] [Abstract][Full Text] [Related]
38. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging. Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792 [TBL] [Abstract][Full Text] [Related]
39. [Clinical significance of transiently elevated serum AFP level in developing hepatocellular carcinoma in HBsAg positive-liver cirrhosis]. Lee HY; Jung JH; Kang YS; Kim YS; Moon HS; Park KO; Lee YS; Kim SM; Seo SW; Lee SW; Kim SH; Lee BS; Kim NJ Korean J Gastroenterol; 2004 Apr; 43(4):252-9. PubMed ID: 15100489 [TBL] [Abstract][Full Text] [Related]
40. Serum AFP and AFP-L3 in clinically distinguished hepatocellular carcinoma from patients with liver masses. Subwongcharoen S; Leelawat K; Treepongkaruna SA; Narong S J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S46-51. PubMed ID: 21717878 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]